Gastroenterology Research of America

Gastroenterology Research of America (GRA) is a specialized clinical research organization and high-volume clinical site network dedicated to Phase II through IV clinical trials in gastroenterology and hepatology. Based in South Florida, the company provides comprehensive clinical trial management services, including patient recruitment, site monitoring, and data collection for major pharmaceutical and biotechnology sponsors. GRA specializes in complex protocols for chronic digestive conditions such as Inflammatory Bowel Disease (IBD), NASH/MASH, and Irritable Bowel Syndrome. Led by experienced board-certified gastroenterologists, the organization is recognized for its high enrollment performance and strict adherence to Good Clinical Practice (GCP) standards. The company serves as a critical link in the drug development lifecycle, facilitating the evaluation of novel small molecules and biologics within the GI therapeutic space.